In several applications such as clinical trials and financial portfolio
optimization, the expected value (or the average reward) does not
satisfactorily capture the merits of a drug or a portfolio. In such
applications, risk plays a crucial role, and a risk-aware performance measure
is preferable, so as to capture losses in the case of adverse events. This
s